NEW YORK (GenomeWeb News) — Helicos BioSciences has begun manufacturing its Heliscope genome sequencer at its facility in Cambridge, Mass., the company said this week.
 
The company also said it is “approach[ing] receipt of our first commercial order.” It did not elaborate.
 
The company, which began trading on the Nasdaq exchange late last month, said it is expecting to launch the Heliscope late this year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.